Back to search results

Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Locally Advanced Intrahepatic Cholangiocarcinoma · Oligometastatic Intrahepatic Cholangiocarcinoma · Stage III Intrahepatic Cholangiocarcinoma AJCC v8 · Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 · Unresectable Intrahepatic Cholangiocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Mayo Clinic in Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Principal Investigator (Umair Majeed, MD)
Study leads

  • Umair Majeed, MD

    Principal Investigator

    Mayo Clinic

View source on ClinicalTrials.gov(opens in a new tab)